We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.24B
AUM Growth
+$139M
Cap. Flow
+$46.3M
Cap. Flow %
0.74%
Top 10 Hldgs %
26.92%
Holding
404
New
21
Increased
154
Reduced
178
Closed
12

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$55.6M
2
OKE icon
Oneok
OKE
+$38.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$38.1M
4
MCD icon
McDonald's
MCD
+$33.4M
5
T icon
AT&T
T
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 16.35%
2 Technology 14.89%
3 Consumer Staples 14.37%
4 Industrials 12.52%
5 Energy 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
226
DELISTED
Hanesbrands
HBI
$707K 0.01%
37,000
+1,548
+4% +$27.8K
DHR icon
227
Danaher
DHR
$141B
$701K 0.01%
13,913
+64
+0.5% +$3.26K
ZTS icon
228
Zoetis
ZTS
$32.4B
$695K 0.01%
24,037
-221
-0.9% -$6.75K
WPC icon
229
W.P. Carey
WPC
$16.4B
$691K 0.01%
11,742
+3,778
+47% +$228K
TBRG
230
DELISTED
TruBridge
TBRG
$690K 0.01%
10,688
+1,293
+14% +$83.9K
IPAR icon
231
Interparfums
IPAR
$3.81B
$677K 0.01%
18,691
+156
+0.8% +$5.24K
EWS icon
232
iShares MSCI Singapore ETF
EWS
$1.06B
$674K 0.01%
25,819
IWR icon
233
iShares Russell Mid-Cap ETF
IWR
$56.7B
$674K 0.01%
17,432
+3,136
+22% +$119K
WST icon
234
West Pharmaceutical
WST
$24.5B
$658K 0.01%
14,941
+526
+4% +$24.8K
GLD icon
235
SPDR Gold Trust
GLD
$138B
$653K 0.01%
5,280
-885
-14% -$110K
GD icon
236
General Dynamics
GD
$105B
$652K 0.01%
5,986
+6
+0.1% +$621
RYN icon
237
Rayonier
RYN
$6.45B
$644K 0.01%
20,698
-989
-5% -$29.7K
SYNT
238
DELISTED
Syntel Inc
SYNT
$643K 0.01%
14,302
+202
+1% +$9.09K
SSYS icon
239
Stratasys
SSYS
$760M
$642K 0.01%
6,053
-292
-5% -$34.9K
HSY icon
240
Hershey
HSY
$36.8B
$634K 0.01%
6,070
EPD icon
241
Enterprise Products Partners
EPD
$82.3B
$628K 0.01%
18,112
+600
+3% +$19.9K
BUD icon
242
AB InBev
BUD
$165B
$621K 0.01%
5,900
-100
-2% -$10.1K
CNL
243
DELISTED
CLECO CRP (HOLDING CO)
CNL
$621K 0.01%
12,280
+930
+8% +$45K
TXRH icon
244
Texas Roadhouse
TXRH
$13.7B
$620K 0.01%
23,777
+427
+2% +$11K
UNFI icon
245
United Natural Foods
UNFI
$2.9B
$620K 0.01%
8,748
+253
+3% +$18K
NVO
246
Novo Nordisk
NVO
$203B
$611K 0.01%
26,760
-1,840
-6% -$39.2K
WM icon
247
Waste Management
WM
$91.5B
$611K 0.01%
14,525
-6,100
-30% -$256K
JJSF icon
248
J&J Snack Foods
JJSF
$1.72B
$607K 0.01%
6,325
+200
+3% +$18.1K
HBAN icon
249
Huntington Bancshares
HBAN
$35.1B
$606K 0.01%
60,803
IBKC
250
DELISTED
IBERIABANK Corp
IBKC
$602K 0.01%
8,583
+108
+1% +$7.06K

Similar funds

Bahl & Gaynor's Q1 2014 Portfolio in Review

As of Q1 2014, Bahl & Gaynor held 404 positions worth $6.24B, up 2.3% from $6.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q1 2014 filing shows 21 new, 154 increased, 178 reduced and 12 closed positions. Its largest new stake was Cencora: 276,922 shares worth $18.2M. The largest sale was Intel, an estimated $55.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Bahl & Gaynor's largest Q1 2014 buy was Cencora: 276,922 shares worth $18.2M.
  • Bahl & Gaynor added most to 3M in Q1 2014, an estimated $83M increase.
  • Bahl & Gaynor's biggest Q1 2014 reduction was Intel, cutting an estimated $55.6M.
  • Bahl & Gaynor fully exited Atrion Corp in Q1 2014, selling an estimated $478K.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.24B portfolio in Q1 2014.
  • Bahl & Gaynor opened 21 new positions and closed 12 in Q1 2014.
  • Bahl & Gaynor's portfolio value rose 2.3% quarter-over-quarter to $6.24B.

Based on Bahl & Gaynor's 13F filing for Q1 2014, filed 20 May 2014.